Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Marcelo de Araujo & Murilo Vilaça. (2022) What Exactly “History Has Taught us”? Enhancing the Socio-Political Perspective in Neuroethics. AJOB Neuroscience 13:1, pages 35-37.
Read now
Read now
Simon Outram. (2019) The Ethics of DTC Neurotechnologies: Mapping Out Social Questions in Advance of Technological Innovation. AJOB Neuroscience 10:4, pages 189-191.
Read now
Read now
Ahmed Dahir Mohamed. (2014) Reducing Creativity With Psychostimulants May Debilitate Mental Health and Well-Being. Journal of Creativity in Mental Health 9:1, pages 146-163.
Read now
Read now
Wayne Hall, Brad Partridge & Jayne Lucke. (2013) Constraints on Regulatory Options for Putatively Cognitive Enhancing Drugs. The American Journal of Bioethics 13:7, pages 35-37.
Read now
Read now
Peter
Shiu-Hwa Tsu. (2012) Methylphenidate and Cigarettes. AJOB Neuroscience 3:2, pages 38-39.
Read now
Read now
WilliamP. Cheshire$suffix/text()$suffix/text(). (2012) Cognitive Enhancements Considered From 221-B Baker Street. AJOB Neuroscience 3:2, pages 35-36.
Read now
Read now
Stephen Rice & David Trafimow. (2012) Rational Decision Making With Regard to Taking Methylphenidate. AJOB Neuroscience 3:2, pages 31-33.
Read now
Read now
NicoleA Vincent. (2012) The Importance of Monitoring in the Adoption of More Liberal Drug Policies. AJOB Neuroscience 3:2, pages 30-31.
Read now
Read now
Eric Racine. (2012) Are the Conditions in Place for the Development of a Strong and Interdisciplinary Neuroethics?. AJOB Neuroscience 3:2, pages 1-2.
Read now
Read now
Aaron Cardon. (2012) The History of Enhancement? Or of Pharmacology?. AJOB Neuroscience 3:2, pages 33-34.
Read now
Read now
Ahmed
Dahir Mohamed. (2012) Modafinil Has the Potential for Addiction. AJOB Neuroscience 3:2, pages 36-38.
Read now
Read now
Articles from other publishers (20)
Razzagh Rahimpoor, Ali Firoozichahak, Saber Alizadeh & Davood Nematollahi. (2022) Urinary bio-monitoring of amphetamine derivatives by needle trap device packed with the zirconium-based metal–organic framework. Scientific Reports 12:1.
Crossref
Crossref
Jonas Schram, Marc Parrilla, Amorn Slosse, Filip Van Durme, Jenny Åberg, Karin Björk, Stefan M. Bijvoets, Sharon Sap, Marcel W.J. Heerschop & Karolien De Wael. (2022) Paraformaldehyde-coated electrochemical sensor for improved on-site detection of amphetamine in street samples. Microchemical Journal 179, pages 107518.
Crossref
Crossref
Teneille R. Brown. (2020) The Role of Dehumanization in Our Response to People With Substance Use Disorders. Frontiers in Psychiatry 11.
Crossref
Crossref
Nausheen Alam & Kulsoom Chaudhary. (2019) Repeated restraint stress potentiates methylphenidate and modafinil-induced behavioral sensitization in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 393:5, pages 785-795.
Crossref
Crossref
Shete Sanmati D., Amane Nikita B., Desai Punam S., Salunkhe .V. R.Dr.Dr. & Magdum C. S.Dr.Dr.. (2019) Design and Development of Brahmi Extract Loaded Nanofibers for Cognitive Disorder and Its Optimization. International Journal of Scientific Research in Science and Technology, pages 104-115.
Crossref
Crossref
Annette B. Brühl, Camilla d’Angelo & Barbara J. Sahakian. (2019) Neuroethical issues in cognitive enhancement: Modafinil as the example of a workplace drug?. Brain and Neuroscience Advances 3, pages 239821281881601.
Crossref
Crossref
Jenny Krutzinna. 2019. Shaping Children. Shaping Children
11
24
.
Veljko Dubljević & Eric Racine. 2019. Shaping Children. Shaping Children
199
212
.
Nausheen Alam & Kulsoom Choudhary. (2018) Haloperidol attenuates Methylphenidate and Modafinil induced behavioural sensitization and cognitive enhancement. Metabolic Brain Disease 33:3, pages 893-906.
Crossref
Crossref
Nathalie Voarino, Veljko Dubljević & Eric Racine. (2017) tDCS for Memory Enhancement: Analysis of the Speculative Aspects of Ethical Issues. Frontiers in Human Neuroscience 10.
Crossref
Crossref
Jayne Lucke, Brad Partridge, Cynthia Forlini & Eric Racine. 2015. Handbook of Neuroethics. Handbook of Neuroethics
1085
1100
.
Mikael Dunlop & Julian Savulescu. (2015) Distributive justice and cognitive enhancement in lower, normal intelligence. Monash Bioethics Review 32:3-4, pages 189-204.
Crossref
Crossref
Ahmed Dahir Mohamed. (2014) Neuroethical issues in pharmacological cognitive enhancement. WIREs Cognitive Science 5:5, pages 533-549.
Crossref
Crossref
Toni Pustovrh & Franc Mali. (2013) Exploring Some Challenges of the Pharmaceutical Cognitive Enhancement Discourse: Users and Policy Recommendations. Neuroethics 7:2, pages 137-158.
Crossref
Crossref
Eric Racine, Tristana Martin Rubio, Jennifer Chandler, Cynthia Forlini & Jayne Lucke. (2014) The value and pitfalls of speculation about science and technology in bioethics: the case of cognitive enhancement. Medicine, Health Care and Philosophy 17:3, pages 325-337.
Crossref
Crossref
William D. Graf & Leon G. Epstein. (2014) No PEDs in Pediatrics. Pediatric Neurology 50:4, pages 288-289.
Crossref
Crossref
Simon M. Outram. (2013) Discourses of performance enhancement: Can we separate performance enhancement from performance enhancing drug use?. Performance Enhancement & Health 2:3, pages 94-100.
Crossref
Crossref
Sebastian AguiarThomas Borowski. (2013)
Neuropharmacological Review of the Nootropic Herb
Bacopa monnieri
. Rejuvenation Research 16:4, pages 313-326.
Crossref
Crossref
Gregor Wolbring, Lucy Diep, Sophya Yumakulov, Natalie Ball, Verlyn Leopatra & Dean Yergens. (2013) Emerging Therapeutic Enhancement Enabling Health Technologies and Their Discourses: What Is Discussed within the Health Domain?. Healthcare 1:1, pages 20-52.
Crossref
Crossref
Brad Partridge. (2013) A re-think on drug policy in sport requires an enhanced conception of enhancement. Performance Enhancement & Health 2:2, pages 76-77.
Crossref
Crossref